More serious issues than the name change

Whilst we debate the resolution for a name change, I feel a more important resolution for discussion is the re-election of the current Chairman.

It's very easy at AGM's to simply tick all the yes boxes but after what we've been through over the last 12 months, in my opinion, we need to consider every resolution carefully.

On his watch as chairman we have seen a plummeting share price, a failure of the company to secure KPI's from the last AGM including published articles, direct licenses (license, license, license) and significant delays in opioid patch development.

A quick poll on hot copper reveals a 20-2 vote against his re-election.

I'm interested to hear other people's views.

Does it concern people that after all this time he has failed to purchase a single share in POH?
Does it concern people on the magnitude of his remuneration package?
What value does he bring to the company?
Do we need to re-elect him with the calibre of directors coming on board?
How does his track record at other companies stack up?

In my opinion, it is important to consider all these factors when ticking the boxes.
I have considered these and side with the majority of no for re-election.


I'm more interested to hear thoughts on this rather than the name change.
Anyone?